{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:39:06Z","timestamp":1792291146556,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["9456"],"award-info":[{"award-number":["9456"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["12369"],"award-info":[{"award-number":["12369"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.trsl.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:38:07Z","timestamp":1781246287000},"page":"95-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The HDAC Inhibitor RM-3-22 Suppresses Triple-Negative Breast Cancer by Uncoupling Autophagy to Drive FSP1-Dependent Ferroptosis"],"prefix":"10.1016","volume":"295","author":[{"given":"Essha","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshiyar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigneshwar Reddy","family":"Ashireddygari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Tammineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-7928","authenticated-orcid":false,"given":"Kunal","family":"Nepali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9287-1836","authenticated-orcid":false,"given":"Santosh Kumar","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.trsl.2026.06.010_bib0001","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2478\/v10019-010-0054-4","article-title":"Triple negative breast cancer - Prognostic factors and survival","volume":"45","author":"Ovcaricek","year":"2011","journal-title":"Radiol Oncol"},{"issue":"SUPPL. 6","key":"10.1016\/j.trsl.2026.06.010_bib0002","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","article-title":"Triple-negative breast cancer: Epidemiological considerations and recommendations","volume":"23","author":"Boyle","year":"2012","journal-title":"Ann Oncol"},{"issue":"10074","key":"10.1016\/j.trsl.2026.06.010_bib0003","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"issue":"S1","key":"10.1016\/j.trsl.2026.06.010_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2011-S1-01","article-title":"Triple-Negative Breast Cancer: An Unmet Medical Need","volume":"16","author":"Hudis","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.trsl.2026.06.010_bib0005","article-title":"Targeting Regulated Cell Death (RCD) with Small-Molecule Compounds in Triple-Negative Breast Cancer: A Revisited Perspective from Molecular Mechanisms to Targeted Therapies","volume":"15","author":"Liao","year":"2022","journal-title":"BioMed Central"},{"issue":"5","key":"10.1016\/j.trsl.2026.06.010_bib0006","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/tbj.13369","article-title":"State of art of advanced triple negative breast cancer","volume":"25","author":"Khosravi-Shahi","year":"2019","journal-title":"Breast J"},{"issue":"June","key":"10.1016\/j.trsl.2026.06.010_bib0007","article-title":"Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier","volume":"240","author":"Sharma","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.trsl.2026.06.010_bib0008","doi-asserted-by":"crossref","unstructured":"Chatterjee E, Sharma R, Dey B. Anticancer activity of RM-3-22 : a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo. 2025;(June):1-19. doi:10.3389\/fphar.2025.1544666.","DOI":"10.3389\/fphar.2025.1544666"},{"issue":"1","key":"10.1016\/j.trsl.2026.06.010_bib0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment Find the latest version : Review series New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.trsl.2026.06.010_bib0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.trsl.2026.06.010_bib0011","first-page":"166","article-title":"Histone deacetylase inhibitors: Molecular mechanisms of action and clinical trials as anti-cancer drugs","volume":"3","author":"Kim","year":"2011","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.06.010_bib0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ajh.26760","article-title":"Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Hristov","year":"2023","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.trsl.2026.06.010_bib0013","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.trsl.2026.06.010_bib0014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.trsl.2026.06.010_bib0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4155\/fmc.12.3","article-title":"Targeted cancer therapy: Giving histone deacetylase inhibitors all they need to succeed","volume":"4","author":"Gryder","year":"2012","journal-title":"Future Med Chem"},{"issue":"6","key":"10.1016\/j.trsl.2026.06.010_bib0016","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jcb.25053","article-title":"Fascaplysin induces caspase mediated crosstalk between apoptosis and autophagy through the inhibition of PI3K\/AKT\/mTOR signaling cascade in human leukemia HL-60 cells","volume":"116","author":"Kumar","year":"2015","journal-title":"J Cell Biochem"},{"issue":"14","key":"10.1016\/j.trsl.2026.06.010_bib0017","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1158\/0008-5472.CAN-14-2312","article-title":"Secalonic Acid-D Represses HIF1\u03b1\/VEGF-Mediated Angiogenesis by Regulating the Akt\/mTOR\/p70S6K Signaling Cascade","volume":"75","author":"Guru","year":"2015","journal-title":"Cancer Res"},{"issue":"December 2016","key":"10.1016\/j.trsl.2026.06.010_bib0018","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.redox.2017.01.016","article-title":"Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells","volume":"11","author":"Yang","year":"2017","journal-title":"Redox Biol"},{"issue":"11","key":"10.1016\/j.trsl.2026.06.010_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05447-8","article-title":"Identification of a group of bisbenzylisoquinoline (BBIQ) compounds as ferroptosis inhibitors","volume":"13","author":"Fan","year":"2022","journal-title":"Cell Death Dis"},{"issue":"January","key":"10.1016\/j.trsl.2026.06.010_bib0020","first-page":"1","article-title":"Natural product manoalide promotes EGFR-TKI sensitivity of lung cancer cells by KRAS-ERK pathway and mitochondrial Ca2+ overload-induced ferroptosis","volume":"13","author":"Ni","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.trsl.2026.06.010_bib0021","first-page":"1","article-title":"Advanced protocols in oxidative stress III, Methods in Molecular Biology","volume":"594","author":"Armstrong","year":"2014","journal-title":"Adv Protoc Oxidative Stress III"},{"issue":"2","key":"10.1016\/j.trsl.2026.06.010_bib0022","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"issue":"5","key":"10.1016\/j.trsl.2026.06.010_bib0023","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/auto.4451","article-title":"Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3","volume":"3","author":"Kimura","year":"2007","journal-title":"Autophagy"},{"issue":"44","key":"10.1016\/j.trsl.2026.06.010_bib0024","first-page":"1","article-title":"Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson\u2019s disease-linked DNAJC6 mutations","volume":"9","author":"Wulansari","year":"2023","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.trsl.2026.06.010_bib0025","first-page":"1","article-title":"Characterization of spontaneous spheroids from oral mucosa-derived cells and their direct comparison with spheroids from skin-derived cells","volume":"10","author":"Li","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.trsl.2026.06.010_bib0026","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","article-title":"Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer","volume":"19","author":"Gy\u0151rffy","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"8","key":"10.1016\/j.trsl.2026.06.010_bib0027","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN : A Portal for Facilitating Tumor Subgroup Gene Expression","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"xxx","key":"10.1016\/j.trsl.2026.06.010_bib0028","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: An update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia (United States)"},{"key":"10.1016\/j.trsl.2026.06.010_bib0029","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhou BP. TNF- a \/NF- k B \/Snail pathway in cancer cell migration and invasion. Published online 2010:639-644. doi:10.1038\/sj.bjc.6605530.","DOI":"10.1038\/sj.bjc.6605530"},{"issue":"January","key":"10.1016\/j.trsl.2026.06.010_bib0030","article-title":"Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway","volume":"921","author":"Chen","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.trsl.2026.06.010_bib0031","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.7150\/ijbs.82120","article-title":"Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer","volume":"19","author":"Chen","year":"2023","journal-title":"Int J Biol Sci"},{"issue":"January","key":"10.1016\/j.trsl.2026.06.010_bib0032","article-title":"HDAC inhibitor cowanin extracted from G. fusca induces apoptosis and autophagy via inhibition of the PI3K\/Akt\/mTOR pathways in Jurkat cells","volume":"147","author":"Punpai","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.trsl.2026.06.010_bib0033","first-page":"1","article-title":"Molecular mechanism leading to SAHA \u2011 induced autophagy in tumor cells : evidence for a p53 \u2011 dependent pathway","author":"Fr\u00f6hlich","year":"2016","journal-title":"Cancer Cell Int"},{"issue":"January","key":"10.1016\/j.trsl.2026.06.010_bib0034","article-title":"HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer","volume":"225","author":"Jenke","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"7784","key":"10.1016\/j.trsl.2026.06.010_bib0035","first-page":"688","volume":"575","author":"Bersuker","year":"2020","journal-title":"HHS Public Access"},{"key":"10.1016\/j.trsl.2026.06.010_bib0036","doi-asserted-by":"crossref","unstructured":"Hadian K. Ferroptosis Suppressor Protein 1 (FSP1) and Coenzyme Q 10 Cooperatively Suppress Ferroptosis. 2020;1:637-638. doi:10.1021\/acs.biochem.0c00030.","DOI":"10.1021\/acs.biochem.0c00030"},{"issue":"December 2020","key":"10.1016\/j.trsl.2026.06.010_bib0037","article-title":"Ferroptosis : molecular mechanisms and health implications","author":"Tang","year":"2021","journal-title":"Cell Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:50:49Z","timestamp":1785963049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S1931524426001210"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.06.010","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The HDAC Inhibitor RM-3-22 Suppresses Triple-Negative Breast Cancer by Uncoupling Autophagy to Drive FSP1-Dependent Ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}